| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.089 | 0.05 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.087 | 0.08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |